市場調査レポート

医薬品包装市場:2012年〜2016年

Pharmaceutical Packaging 2012 to 2016

発行 Allied Development Corp. 商品コード 235030
出版日 ページ情報 英文 440 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
医薬品包装市場:2012年〜2016年 Pharmaceutical Packaging 2012 to 2016
出版日: 2012年03月26日 ページ情報: 英文 440 Pages
概要

当レポートでは、世界の医薬品包装市場について調査し、市場概要、技術および機会を分析しており、新しい医薬品の開発、消費者のニーズと期待、地域的影響、政府の規制、OTCvs.エシカル製品の包装、および包装の革新などについて取り上げ、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 エグゼクティブサマリーて

  • 市場促進因子・動向
  • 市場予測

第3章 技術

  • 技術プライオリティ
  • デバイスvs.パッケージ
  • 一次包装
  • 二次包装
  • コンプライアンス包装
  • チャイルドプルーフ包装
  • 開封明示包装
  • 1回量包装
  • 偽造防止包装
  • ラベリング
  • ID・追跡
  • アクティブ包装
  • 無菌医薬品の包装工程
  • 非菌医薬品の包装工程
  • 医薬品包装材料
  • 包装構造
  • 医薬品包装装置の技術

第4章 市場動向・予測

  • 医薬品市場の促進因子・動向
  • 医薬品包装市場の促進因子・動向
  • 世界の一次包装量:デリバリー法別
  • 世界の一次包装量:包装タイプ別
  • 世界の一次包装額:包装タイプ別
  • BRIC諸国の一次包装量:包装タイプ別
  • 欧州の一次包装量:包装タイプ別
  • 日本の一次包装量:包装タイプ別
  • 北米の一次包装量:包装タイプ別
  • その他の一次包装量:包装タイプ別
  • 世界の一次包装量:地域別
  • 世界の二次包装量:包装タイプ別
  • 世界の二次包装額:包装タイプ別
  • 一次包装量:規制状況別
  • 一次包装量:医薬品の生産工程別
  • 一次包装量:流通チャネル別
  • 一次包装量:コンプライアンス特徴別
  • 一次包装量:偽造防止別
  • 一次包装量:チャイルドプルーフ別
  • 一次包装量:いたずら防止機能別
  • 一次包装量:材料タイプ別

第5章 生産業者

第6章 装置サプライヤー

第7章 用語集

目次
Product Code: RPP12A

Abstract

"Pharmaceutical Packaging 2012 to 2016" examines the global pharmaceutical packaging industry, an important partner with the pharmaceutical industry, one of the worldxs most important, powerful, and sophisticated industries. This comprehensive Study analyzes markets, technologies, and opportunities for drug packaging, and presents their global ramifications as an aid to effective decision-making and strategy development.

The Study identifies and tracks the trajectory of market-driving forces from around the world, including the expected impacts on global drug packaging from:

  • new drug product development
  • consumer needs and expectations
  • geographic influences
  • governmental regulations
  • packaging for OTC vs. ethical products
  • packaging innovations

The Study's in-depth analyses of these factors help generate Global Growth Forecasts that will be of keen interest to decision-makers who are engaged with pharmaceutical packaging. For example, quantitative forecasts are included for packaging types (primary and secondary) and materials, packaging consumed within multiple geographic regions, and the growth of package design solutions to provide functionality for patient compliance, anti-counterfeiting, child-resistance or tamper evidence.

Table of Contents

Section I:

Introduction

  • A. Pharmaceuticals defined
  • B. Pharmaceutical packaging defined
  • C. Study organization
  • D. Methodology
  • E. Geographic regions
  • F. Conventions

Section II:

Executive Summary

  • A. Drivers and trends
    • 1. Consumer needs
    • 2. Healthcare system costs
    • 3. Biologics
    • 4. Generic and over-the-counter (OTC) markets
    • 5. Drug delivery methods
    • 6. Child resistance
    • 7. Anti-counterfeiting
    • 8. Tamper evidence
    • 9. Patient compliance
  • B. Market projections
    • 1. Global primary packaging volume by drug delivery method
    • 2. Global primary packaging volume by package type
    • 3. Global primary packaging value segmented by package type
    • 4. Global secondary packaging volume segmented by package type
    • 5. Global secondary packaging value segmented by package type
    • 6. Global primary packaging volume by geographic region
    • 7. Global primary packaging volume segmented by regulatory status
    • 8. Global primary packaging volume by drug production process
    • 9. Global primary packaging volume by distribution channel
    • 10. Global primary packaging volume by patient compliance
    • 11. Global primary packaging volume by anti-counterfeit solutions
    • 12. Global primary packaging volume by child-resistance

Section III:

Technology

  • A. Technology priorities
    • 1. Drug safety and efficacy
    • 2. Drug sensitivity
    • 3. Drug delivery method
    • 4. Regulations - drug safety and efficacy
    • 5. Packaging cost
    • 6. Environment and health
    • 7. Packaging requirements
  • B. Devices versus packages
    • 1. Inhalers
    • 2. Pen injection systems
    • 3. Auto-injectors
  • C. Primary packaging
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. Intravenous (IV) bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other primary containers
    • 13. Innerseals
    • 14. Closures
  • D. Secondary packaging
    • 1. Folding cartons
    • 2. Blister cards and wallets
    • 3. Shrink bands
    • 4. Labels
    • 5. Other
  • E. Compliance packaging
  • F. Child-resistant packaging
    • 1. Multi-dose packaging
    • 2. Unit-dose packaging
    • 3. Additional child-resistant technologies
  • G. Tamper-evident packaging
  • H. Unit-dose packaging
  • I. Anti-counterfeit packaging
    • 1. Overt solutions
    • 2. Covert solutions
    • 3. Summary
  • J. Labelling
  • K. Identification and tracking
    • 1. Barcodes
    • 2. Radio frequency identification (RFID)
  • L. Active packaging
  • M. Packaging processes for sterile drugs
    • 1. Traditional aseptic packaging
    • 2. Aseptic packaging with barrier isolation technology
    • 3. Terminal sterilization (in-package sterilization)
  • N. Packaging processes for non-sterile drugs
  • O. Pharmaceutical packaging materials
    • 1. Polymers
    • 2. Glass
    • 3. Aluminum foil
    • 4. Paper
    • 5. Paperboard
    • 6. Other
  • P. Packaging structures
    • 1. Blister pack structures
    • 2. Bottles, vials, ampules, cartridges, and mini-jars
    • 3. Pouch structures
    • 4. Pre-filled syringes
    • 5. IV bags
    • 6. Tube structures
    • 7. Secondary packaging
    • 8. Other structures
  • Q. Pharmaceutical packaging equipment technology
    • 1. Filling equipment
    • 2. Filling equipment suppliers

Section IV:

Market Trends and Projections

  • A. Pharmaceutical industry drivers and trends
    • 1. Government policies
    • 2. Macro environment
    • 3. New drugs
    • 4. New drug delivery techniques
    • 5. Biologics
    • 6. Generic drugs
    • 7. Delivery devices
    • 8. New drug production techniques
  • B. Pharmaceutical packaging industry drivers and trends
    • 1. Underlying product trends
    • 2. Regulatory environment
    • 3. Government healthcare programs
    • 4. Product differentiation
    • 5. Drug safety
    • 6. Conversions from prescription to OTC
    • 7. Alternative drug delivery methods
    • 8. Environmental
    • 9. Drug protection requirements
  • C. Global primary packaging volume by delivery method
    • 1. Cutaneous
    • 2. Inhaled
    • 3. Nasal
    • 4. Ocular
    • 5. Oral delivery
    • 6. Parenteral
    • 7. Transdermal
    • 8. Other
  • D. Global primary packaging volume by package type
    • 1. Ampules
    • 2. Blister packs
    • 3. Bottles
    • 4. Canisters
    • 5. Cartridges
    • 6. IV bags
    • 7. Mini-jars
    • 8. Pouches
    • 9. Pre-fillable syringes
    • 10. Tubes
    • 11. Vials
    • 12. Other
    • 13. Closures
    • 14. Fitments
    • 15. Innerseals
    • 16. Valves
  • E. Global primary packaging value segmented by package type
  • F. BRIC primary packaging volume by packaging type
  • G. Europe primary packaging volume by packaging type
  • H. Japan primary packaging volume by packaging type
  • I. North America primary packaging volume by package type
  • J. ROW primary packaging volume by packaging type
  • K. Global primary packaging volume by geographic region
    • 1. BRIC
    • 2. Europe
    • 3. Japan
    • 4. North America
    • 5. Rest of World (ROW)
    • L. Global primary packaging value by geographic region
  • M. Global secondary packaging volume by package type
    • 1. Blister cards and wallets
    • 2. Folding cartons
    • 3. Trays
    • 4. Other
    • 5. Labels
    • 6. Shrink bands
  • N. Global secondary packaging value by package type
  • O. Primary packaging volume segmented by regulatory status
    • 1. Over-the-counter pharmaceuticals
    • 2. Prescription
    • 3. Projection
  • P. Primary packaging volume by drug production process
    • 1. Chemical
    • 2. Biological
    • 3. Projection
  • Q. Primary packaging volume by distribution channel
    • 1. Institutional
    • 2. Retail
    • 3. Projection
  • R. Primary packaging volume segmented by compliance features
    • 1. Compliance
    • 2. Projection
  • S. Primary packaging volume segmented by anti-counterfeiting
    • 1. Anti-counterfeit
    • 2. Projection
  • T. Primary packaging volume by child resistance
    • 1. Child resistance
    • 2. Projection
  • U. Primary packaging volume by tamper evidence
    • 1. Tamper evidence
    • 2. Projection
  • V. Primary packaging volume segmented by material type
    • 1. Primary packaging
    • 2. Blister pack
    • 3. Tubes
    • 4. Pouches and strip packs
    • 5. Secondary packaging

Section V:

  • Packaging Producers

Section VI:

  • Equipment Suppliers

Section VII:

  • Glossary
Back to Top